Literature DB >> 22904138

Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.

Rachel R Wang1, Darrell J Triulzi, Lirong Qu.   

Abstract

The purpose of this study was to assess the incidence of febrile nonhemolytic transfusion reactions (FNHTRs) to concurrent transfusions of prestorage-leukoreduced (PreSLR) pooled platelets, poststorage-leukoreduced (PostSLR) pooled platelets, nonleukoreduced (NonLR) pooled platelets, and apheresis single-donor platelets (SDPs) to compare the rates of FNHTRs to PreSLR vs PostSLR pooled platelets. Reported transfusion reactions to platelets at 15 hospitals for a period of 45 months were retrospectively reviewed. Reaction rates to different types of platelet products were calculated and compared. During the study period, 70,015 platelet transfusions were administered. Among these, 152 (0.22%) FNHTRs and 111 (0.16%) allergic transfusion reactions were seen. Reported rates of FNHTRs were 0.07% (SDP), 0.16% (PreSLR), 0.30% (PostSLR), and 0.20% (NonLR) (P < .05 for PreSLR vs PostSLR). Rates of allergic reactions were 0.16% (SDP), 0.17% (PreSLR), 0.18% (PostSLR), and 0.11% (NonLR) (P > .05). The rates of reported FNHTRs were low for all types of platelet transfusions. SDPs and PreSLR pooled platelets were associated with a slightly lower rate of FNHTR compared with PostSLR pooled platelets.

Entities:  

Mesh:

Year:  2012        PMID: 22904138     DOI: 10.1309/AJCP5H7EKZTGGBKZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

2.  Plasma Transfusion Products and Contamination with Cellular and Associated Pro-Inflammatory Debris.

Authors:  Yong B Tan; Richard R Rieske; Jon P Audia; Viktor M Pastukh; Gina C Capley; Mark N Gillespie; Alison A Smith; Danielle M Tatum; Juan C Duchesne; Matt E Kutcher; Jeffrey D Kerby; Jon D Simmons
Journal:  J Am Coll Surg       Date:  2019-04-25       Impact factor: 6.113

3.  What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Meghan Delaney; Oliver Karam; Lani Lieberman; Katherine Steffen; Jennifer A Muszynski; Ruchika Goel; Scot T Bateman; Robert I Parker; Marianne E Nellis; Kenneth E Remy
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

4.  Relationship between allergic sensitisation-associated single-nucleotide polymorphisms and allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric cases.

Authors:  Yuichiro Ide; Ryu Yanagisawa; Jun Kobayashi; Kazutoshi Komori; Kazuyuki Matsuda; Yuji Amano; Yozo Nakazawa; Toshikazu Takeshita; Kazuo Sakashita; Minoru Tozuka
Journal:  Blood Transfus       Date:  2021-02-03       Impact factor: 3.443

Review 5.  Platelet transfusion - the new immunology of an old therapy.

Authors:  Moritz Stolla; Majed A Refaai; Joanna M Heal; Sherry L Spinelli; Olivier Garraud; Richard P Phipps; Neil Blumberg
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

6.  Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in Korea.

Authors:  Jooyoung Cho; Seung Jun Choi; Sinyoung Kim; Essam Alghamdi; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

7.  Associated Factors With Acute Transfusion Reaction From Hospital Online Reporting Events: A Retrospective Cohort Study.

Authors:  Chao-Yuan Yao; Ju-Huei Chien; Hsun-Yang Chuang; Tsing-Fen Ho
Journal:  J Patient Saf       Date:  2020-12       Impact factor: 2.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.